Samorita Hospital Limited announcements
287 Dhaka Stock Exchange announcements for Samorita Hospital Limited (SAMORITA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2024 (20).
- Category Change
The Company will be placed in 'B' category from existing 'A' category with effect from December 29, 2024 as the Company has approved 5% Cash Dividend for the year ended June 30, 2024.
- Sale Declaration of a Director
Ms. Shamsa Chowdhury, a director of the company, has expressed her intention to sell 1,25,000 shares out of her total holding of 20,06,018 shares of the Company at prevailing market price (In the Public and Block Market) through Dhaka Stock Exchange PLC. within next 30 working days.
- Resumption after Record Date
Trading of the shares of the company will resume on 20.11.2024.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 19.11.2024.
- Qualified Opinion
The auditor of the company has given the "Qualified Opinion" paragraphs in the Auditor's Report of the company for the year ended June 30, 2024. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2024/November/SAMORITA_2024.pdf
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 17.11.2024 to 18.11.2024 and trading of the shares of the company will remain suspended on record date i.e., 19.11.2024.
- Credit Rating Result
Credit Rating Agency of Bangladesh Limited (CRAB) has assigned Surveillance entity rating of the Company as "A3" in the long term along with Stable outlook based on audited financial statements up to June 30, 2022-2024, bank liability position as on October 31, 2024 and other information up to the date of rating declaration.
- Dividend Declaration
The Board of Directors has recommended 5.00% Cash Dividend for the year ended June 30, 2024. Date of AGM: 26.12.2024, Time: 11:00 AM, Venue: Digital Platform. Record Date: 19.11.2024. The Company has also reported EPS of Tk. 0.56, NAV per share of Tk. 48.27 and NOCFPS of Tk. 2.04 for the year ended June 30, 2024 as against Tk. 0.03, Tk. 43.99 and Tk. 1.22 respectively for the year ended June 30, 2023.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (29.10.2024) following its corporate declaration.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.25 for July-September 2024 as against Tk. 0.84 for July-September 2023; NOCFPS was Tk. 0.53 for July-September 2024 as against Tk. 1.82 for July-September 2023. NAV per share was Tk. 48.52 as on September 30, 2024 and Tk. 48.27 as on June 30, 2024. Reasons for significant deviation in NOCFPS: NOCFPS decreased due to cash receipts from customers have been decreased by Tk. 2.02 Crore.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2024 at 7:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2024 at 7:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.
- (Q3 Un-audited): EPS was Tk. 0.02 for January-March 2024 as against Tk. 0.09 for January-March 2023; EPS was Tk. 0.92 fo
(Q3 Un-audited): EPS was Tk. 0.02 for January-March 2024 as against Tk. 0.09 for January-March 2023; EPS was Tk. 0.92 for July 2023-March 2024 as against Tk. 0.40 for July 2022-March 2023. NOCFPS was Tk. 2.34 for July 2023-March 2024 as against Tk. 1.77 for July 2022-March 2023. NAV per share was Tk. 50.26 as on March 31, 2024 and Tk. 43.99 as on June 30, 2023. (Cont.)
- Q3 Financials
(Continuation news of SAMORITA): Reason for deviation in NOCFPS and NAVPS: NOCFPS increased from Tk. 1 .77 lo Tk.2.34 due to cash receipts from customers have been increased by Tk.4.14 crore and cash paid to suppliers and employees have been increased by Tk.2.97 crore resulting a net increase in cash generated from operation by Tk.1 .1 7 crore. NAVPS increased by Tk. 6.27 due to revaluation gain on land and usual business activities of the company. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2024 at 07:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2024.
- (Q2 Un-audited): EPS was Tk. 0.06 for October-December 2023 as against Tk. 0.18 for October-December 2022; EPS was Tk. 0
(Q2 Un-audited): EPS was Tk. 0.06 for October-December 2023 as against Tk. 0.18 for October-December 2022; EPS was Tk. 0.90 for July-December 2023 as against Tk. 0.31 for July-December 2022. NOCFPS was Tk. 1.97 for July-December 2023 as against Tk. 1.20 for July-December 2022. NAV per share was Tk. 50.24 as on December 31, 2023 and Tk. 43.99 as on June 30, 2023. (cont.)
- Q2 Financials
(Continuation news of SAMORITA): Reasons for deviation in EPS, NOCFPS and NAVPS: EPS has increased due to increase in revenue, decrease in cost of direct materials and administrative expenses as compared to previous corresponding period. NOCFPS has increased due to increase in cash receipts from customers. NAVPS has increased due to revaluation gain on land and usual business activities of the company. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2024 at 7:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.
- Dividend Disbursement
The Company has informed that it has credited the Bonus Shares for the year ended June 30, 2023 to the respective shareholders' BO Accounts.
- Sale Confirmation of a Sponsor Director
Dr. A. B. M. Haroon, one of the Sponsor Directors of the company, has further informed that he has completed his sale of 1,00,000 shares of the Company at prevailing market price through Dhaka Stock Exchange Limited as per declaration disseminated on 12.12.2023.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.